US-based company that deals with diagnostic information services Quest Diagnostics (NYSE: DGX) announced its quarterly cash dividend on Wednesday 14 August.
The company has declared quarterly cash dividend of USD0.75 per share. The dividend will be paid to shareholders of record at 4 October 2024 on 21 October 2024.
Quest provides diagnostic insights from the results of its laboratory testing to empower people, physicians and organisations to take action to improve health outcomes.
Amgen announces Q3 2024 dividend
Perrigo announces quarterly dividend
Valneva receives CEPI funding to boost access to world's first chikungunya vaccine
Emmaus Life Sciences reports 2023 financial results
Quest Diagnostics to acquire LifeLabs from OMERS for USD1.35bn
Eli Lilly announces Q3 2024 dividend
Valneva's chikungunya vaccine IXCHIQ approved by Health Canada